VASCEPA....DATA way to good...FDA will like it

Discussion in 'Amarin' started by Woody, Aug 18, 2019 at 1:33 PM.

  1. Woody

    Woody new user

    Joined:
    Jul 5, 2019
    Messages:
    132
    Likes Received:
    0
    The data is so good the FDA wants to see it for themselves. The reduce-it trial was by far one of the best trials of any heart drugs. Diabetics and people who take statins should probably be on it. Do you know how big the side effect of muscle pain is with statins...it's a lot and the longer you take them more likely it will show up.
     

  2. anonymous

    anonymous Guest

     
  3. anonymous

    anonymous Guest

    You meal Wal Mart? Are you from the USA? Asking seriously.
     
  4. anonymous

    anonymous Guest

     
  5. anonymous

    anonymous Guest